Trial Profile
Treatment of patients with advanced rectal cancer with capecitabine plus oxaliplatin before, during and after the intentional curative radiation therapy, and the addition of cetuximab in patients who are K-ras wild-type.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jun 2018
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Capecitabine; Oxaliplatin
- Indications Rectal cancer
- Focus Therapeutic Use
- 15 Jun 2018 Status changed from recruiting to completed.
- 08 Dec 2016 New trial record